Multiple endocrine neoplasia type 2 prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Secondary Prevention== * Ionized calcium level yearly for MEN 2A * Parathyroid hormone level yearly for MEN 2A * Catacho...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== |
Revision as of 20:36, 26 September 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 prevention On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 prevention |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Secondary Prevention
- Ionized calcium level yearly for MEN 2A
- Parathyroid hormone level yearly for MEN 2A
- Catacholamines, epinephrine and norepinephrine yearly for MEN 2A and MEN 2B
- Magnetic resonance imaging and computerized tomography for pheochromocytoma every 2-4 years